Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 13, 2017
April 17, 2020
c324ad2d-8447-448c-b0ed-664984cf9ba6
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Residual Drug in Transdermal and Related Drug Delivery Systems: Guidance for Industry
Guidance DocumentAugust 17, 2011Center for Drug Evaluation and Research
Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Guidance DocumentMarch 13, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.